Sientra, Inc. Logo

Sientra, Inc.

SIEN

(1.8)
Stock Price

0,17 USD

-60.38% ROA

414.58% ROE

-0.11x PER

Market Cap.

7.179.403,00 USD

-196.41% DER

0% Yield

-71.14% NPM

Sientra, Inc. Stock Analysis

Sientra, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Sientra, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (752.29%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

The stock's low PBV ratio (-0.48x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a low debt to equity ratio (-345%), which means it has a small amount of debt compared to the ownership it holds

4 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

5 ROA

The stock's ROA (-57.08%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-1) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Sientra, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Sientra, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Sientra, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Sientra, Inc. Revenue
Year Revenue Growth
2012 10.447.000
2013 35.171.000 70.3%
2014 44.733.000 21.38%
2015 38.106.000 -17.39%
2016 20.734.000 -83.79%
2017 36.542.000 43.26%
2018 68.126.000 46.36%
2019 83.699.000 18.61%
2020 71.241.000 -17.49%
2021 80.683.000 11.7%
2022 90.549.000 10.9%
2023 78.176.000 -15.83%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Sientra, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2012 3.670.000
2013 4.479.000 18.06%
2014 4.707.000 4.84%
2015 7.199.000 34.62%
2016 9.704.000 25.81%
2017 9.813.000 1.11%
2018 10.945.000 10.34%
2019 13.537.000 19.15%
2020 10.311.000 -31.29%
2021 10.456.000 1.39%
2022 14.063.000 25.65%
2023 9.904.000 -41.99%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Sientra, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 9.938.000
2013 18.078.000 45.03%
2014 10.712.000 -68.76%
2015 18.738.000 42.83%
2016 23.577.000 20.52%
2017 41.537.000 43.24%
2018 42.418.000 2.08%
2019 46.771.000 9.31%
2020 38.191.000 -22.47%
2021 31.773.000 -20.2%
2022 41.532.000 23.5%
2023 30.480.000 -36.26%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Sientra, Inc. EBITDA
Year EBITDA Growth
2012 -23.145.000
2013 -17.973.000 -28.78%
2014 -3.639.000 -393.9%
2015 -23.855.000 84.75%
2016 -40.007.000 40.37%
2017 -59.779.000 33.08%
2018 -75.882.000 21.22%
2019 -80.761.000 6.04%
2020 -57.705.000 -39.95%
2021 -35.424.000 -62.9%
2022 -62.272.000 43.11%
2023 -29.536.000 -110.83%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Sientra, Inc. Gross Profit
Year Gross Profit Growth
2012 8.095.000
2013 26.579.000 69.54%
2014 33.233.000 20.02%
2015 27.452.000 -21.06%
2016 13.854.000 -98.15%
2017 22.371.000 38.07%
2018 41.304.000 45.84%
2019 50.687.000 18.51%
2020 38.939.000 -30.17%
2021 44.335.000 12.17%
2022 41.594.000 -6.59%
2023 40.116.000 -3.68%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Sientra, Inc. Net Profit
Year Net Profit Growth
2012 -23.433.000
2013 -19.125.000 -22.53%
2014 -5.811.000 -229.12%
2015 -41.230.000 85.91%
2016 -40.166.000 -2.65%
2017 -64.028.000 37.27%
2018 -82.627.000 22.51%
2019 -106.818.000 22.65%
2020 -89.947.000 -18.76%
2021 -62.519.000 -43.87%
2022 -73.720.000 15.19%
2023 -59.092.000 -24.75%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Sientra, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 -26
2013 -21 -25%
2014 -23 9.09%
2015 -26 15.38%
2016 -22 -18.18%
2017 -33 33.33%
2018 -33 -3.13%
2019 -26 -23.08%
2020 -18 -52.94%
2021 -11 -70%
2022 -10 0%
2023 -5 -100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Sientra, Inc. Free Cashflow
Year Free Cashflow Growth
2012 -30.240.000
2013 -25.948.000 -16.54%
2014 11.000 235990.91%
2015 -19.312.000 100.06%
2016 -35.556.000 45.69%
2017 -47.780.000 25.58%
2018 -57.045.000 16.24%
2019 -91.104.000 37.38%
2020 -64.164.000 -41.99%
2021 -46.305.000 -38.57%
2022 -38.878.000 -19.1%
2023 -3.636.000 -969.25%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Sientra, Inc. Operating Cashflow
Year Operating Cashflow Growth
2012 -29.846.000
2013 -25.877.000 -15.34%
2014 450.000 5850.44%
2015 -18.184.000 102.47%
2016 -34.430.000 47.19%
2017 -45.916.000 25.02%
2018 -56.190.000 18.28%
2019 -87.033.000 35.44%
2020 -60.127.000 -44.75%
2021 -42.500.000 -41.48%
2022 -35.287.000 -20.44%
2023 -3.366.000 -948.34%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Sientra, Inc. Capital Expenditure
Year Capital Expenditure Growth
2012 394.000
2013 71.000 -454.93%
2014 439.000 83.83%
2015 1.128.000 61.08%
2016 1.126.000 -0.18%
2017 1.864.000 39.59%
2018 855.000 -118.01%
2019 4.071.000 79%
2020 4.037.000 -0.84%
2021 3.805.000 -6.1%
2022 3.591.000 -5.96%
2023 270.000 -1230%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Sientra, Inc. Equity
Year Equity Growth
2012 -107.640.000
2013 -126.673.000 15.03%
2014 95.639.000 232.45%
2015 118.871.000 19.54%
2016 83.617.000 -42.16%
2017 27.623.000 -202.71%
2018 66.878.000 58.7%
2019 81.882.000 18.32%
2020 -557.000 14800.54%
2021 40.857.000 101.36%
2022 -822.000 5070.44%
2023 -32.045.000 97.43%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Sientra, Inc. Assets
Year Assets Growth
2012 69.358.000
2013 53.166.000 -30.46%
2014 139.078.000 61.77%
2015 140.805.000 1.23%
2016 114.283.000 -23.21%
2017 92.213.000 -23.93%
2018 168.359.000 45.23%
2019 204.404.000 17.63%
2020 168.978.000 -20.96%
2021 199.904.000 15.47%
2022 165.421.000 -20.85%
2023 139.933.000 -18.21%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Sientra, Inc. Liabilities
Year Liabilities Growth
2012 176.998.000
2013 179.839.000 1.58%
2014 43.439.000 -314%
2015 21.934.000 -98.04%
2016 30.666.000 28.47%
2017 64.590.000 52.52%
2018 101.481.000 36.35%
2019 122.522.000 17.17%
2020 169.535.000 27.73%
2021 159.047.000 -6.59%
2022 166.243.000 4.33%
2023 171.978.000 3.33%

Sientra, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
8
Net Income per Share
-5.69
Price to Earning Ratio
-0.11x
Price To Sales Ratio
0.08x
POCF Ratio
-0.58
PFCF Ratio
-0.49
Price to Book Ratio
-0.21
EV to Sales
0.61
EV Over EBITDA
-1.26
EV to Operating CashFlow
-4.67
EV to FreeCashFlow
-3.78
Earnings Yield
-9.48
FreeCashFlow Yield
-2.03
Market Cap
0,01 Bil.
Enterprise Value
0,06 Bil.
Graham Number
19.06
Graham NetNet
-10.2

Income Statement Metrics

Net Income per Share
-5.69
Income Quality
0.2
ROE
4.15
Return On Assets
-0.46
Return On Capital Employed
4.24
Net Income per EBT
1.08
EBT Per Ebit
1.15
Ebit per Revenue
-0.57
Effective Tax Rate
-0.16

Margins

Sales, General, & Administrative to Revenue
0.38
Research & Developement to Revenue
0.13
Stock Based Compensation to Revenue
0.07
Gross Profit Margin
0.42
Operating Profit Margin
-0.57
Pretax Profit Margin
-0.66
Net Profit Margin
-0.71

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-1.04
Free CashFlow per Share
-1.29
Capex to Operating CashFlow
0.24
Capex to Revenue
-0.03
Capex to Depreciation
-0.39
Return on Invested Capital
-1.71
Return on Tangible Assets
-0.6
Days Sales Outstanding
119.69
Days Payables Outstanding
36.89
Days of Inventory on Hand
274.17
Receivables Turnover
3.05
Payables Turnover
9.89
Inventory Turnover
1.33
Capex per Share
-0.25

Balance Sheet

Cash per Share
1,33
Book Value per Share
-2,84
Tangible Book Value per Share
-5.81
Shareholders Equity per Share
-2.84
Interest Debt per Share
6.48
Debt to Equity
-1.96
Debt to Assets
0.45
Net Debt to EBITDA
-1.1
Current Ratio
0.57
Tangible Asset Value
-0,07 Bil.
Net Current Asset Value
-0,09 Bil.
Invested Capital
-1.96
Working Capital
-0,07 Bil.
Intangibles to Total Assets
0.24
Average Receivables
0,03 Bil.
Average Payables
0,01 Bil.
Average Inventory
39338000
Debt to Market Cap
8.77

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Sientra, Inc. Dividends
Year Dividends Growth

Sientra, Inc. Profile

About Sientra, Inc.

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

CEO
Mr. Ronald Menezes
Employee
304
Address
420 South Fairview Avenue
Santa Barbara, 93117

Sientra, Inc. Executives & BODs

Sientra, Inc. Executives & BODs
# Name Age
1 Mr. Oliver Christian Bennett
Senior Vice President, Chief Legal, Compliance, & Corporate Development Officer
70
2 Mr. Ronald Menezes
President, Chief Executive Officer & Director
70
3 Ms. Adelle Walker
Senior Vice President of Corporate Strategy & Marketing
70
4 Mr. Keith J. Sullivan
Director & Advisor to MiraDry Business
70
5 Mr. Andrew C. Schmidt
Senior Vice President, Treasurer & Chief Financial Officer
70
6 Ms. Caroline F. Van Hove
Executive Chair of Board of Directors
70
7 Dr. Denise Dajles
Chief Technical Officer
70
8 Mr. Mark S. Saxton
Senior Vice President Sales
70
9 Mr. Matt Hostetler
Chief People Officer
70

Sientra, Inc. Competitors

AxoGen, Inc. Logo
AxoGen, Inc.

AXGN

(1.2)
Ainos, Inc. Logo
Ainos, Inc.

AIMD

(1.2)
LENSAR, Inc. Logo
LENSAR, Inc.

LNSR

(1.2)
Paragon 28, Inc. Logo
Paragon 28, Inc.

FNA

(1.5)
CVRx, Inc. Logo
CVRx, Inc.

CVRX

(1.0)
Heska Corporation Logo
Heska Corporation

HSKA

(1.0)
NeuroPace, Inc. Logo
NeuroPace, Inc.

NPCE

(0.5)
Inogen, Inc. Logo
Inogen, Inc.

INGN

(1.2)
Surmodics, Inc. Logo
Surmodics, Inc.

SRDX

(0.8)
Pulmonx Corporation Logo
Pulmonx Corporation

LUNG

(1.2)
Artivion, Inc. Logo
Artivion, Inc.

AORT

(0.5)
Eargo, Inc. Logo
Eargo, Inc.

EAR

(1.8)